Skip to main content
Navigate Up
Sign In
 

CU studies paved way for artificial pancreas approval


​The world’s first artificial pancreas is coming to market much sooner than anyone expected – including the University of Colorado School of Medicine researchers whose work has been so central to the device’s development and approval.
 
The U.S. Food and Drug Administration on Sept. 28 approved the Medtronic MiniMed 670G system for patients 14 years and older with type 1 diabetes. The approval cites a clinical trial for which CU’s Barbara Davis Center for Childhood Diabetes was the largest proving ground.
 
“It’s a game-changer for people with diabetes,” said Satish Garg, MD, chief of the Barbara Davis Center’s adult clinic, who led the local study cohort.